HIV trial under scrutiny

Critics say that antibody therapy is too expensive for its African target population.

Read More
Publication Date: 
17/01/2013
Meredith Wadman
Nature
493
7432
279-280
Tags:
AIDS, Medical Research, Africa, Child Health, United States Of America (US), Drugs